Correction: Future directions for using estrogen receptor agonists in the treatment of acute and chronic spinal cord injury

Swapan K. Ray, Supriti Samantaray, Naren L Banik

1 Department of Pathology, Microbiology, and Immunology, University of South Carolina School of Medicine, Columbia, SC, USA

2 Department of Neurosciences, Medical University of South Carolina, Charleston, SC, USA

3 Department of Neurology and Neurosurgery, Medical University of South Carolina, Charleston, SC; Ralph H. Johnson Veterans Administration Medical Center, Charleston, SC, USA

CORRECTION

Correction: Future directions for using estrogen receptor agonists in the treatment of acute and chronic spinal cord injury

Swapan K. Ray1,*, Supriti Samantaray2, Naren L Banik3

1 Department of Pathology, Microbiology, and Immunology, University of South Carolina School of Medicine, Columbia, SC, USA

2 Department of Neurosciences, Medical University of South Carolina, Charleston, SC, USA

3 Department of Neurology and Neurosurgery, Medical University of South Carolina, Charleston, SC; Ralph H. Johnson Veterans Administration Medical Center, Charleston, SC, USA

Reference

Ray SK, Samntaray S, Banik NL (2016) Future directions for using estrogen receptor agonists in the treatment of acute and chronic spinal cord injury. Neural Regen Res 11:1418-1419.

*Correspondence to: Swapan K. Ray, Ph.D., swapan.ray@uscmed.sc.edu.

The original version of this article contained a typographical error in the spelling of the author Supriti Samantaray, which was incorrectly given as Supriti Samntaray.

The online version of the original article can be found under.

10.4103/1673-5374.191212.

Neural Regeneration Research would like to apologize to the authors and readers for the error and any confusion this may have caused.

doi: 10.4103/1673-5374.200818